Dr. Charlie Richart of the University of Kansas Hospital used a blood substitute called Hemopure to treat internal hemorrhaging due to bleeding polyps in a man who could not receive a blood transfusion. The FDA granted a special compassionate care dispensation for treatment with the hemoglobin-based oxygen carrier. The patient's life was at risk in the case, Richart said.

Related Summaries